CN114569686A - 一种解酒组合物、具有解酒功效的片剂及其制备方法 - Google Patents
一种解酒组合物、具有解酒功效的片剂及其制备方法 Download PDFInfo
- Publication number
- CN114569686A CN114569686A CN202210347978.XA CN202210347978A CN114569686A CN 114569686 A CN114569686 A CN 114569686A CN 202210347978 A CN202210347978 A CN 202210347978A CN 114569686 A CN114569686 A CN 114569686A
- Authority
- CN
- China
- Prior art keywords
- parts
- tablet
- hangover
- effect
- alcoholism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 230000002075 anti-alcohol Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 201000007930 alcohol dependence Diseases 0.000 claims abstract description 35
- 240000008042 Zea mays Species 0.000 claims abstract description 30
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 30
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 30
- 235000005822 corn Nutrition 0.000 claims abstract description 30
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 28
- 241001313710 Dictyophora indusiata Species 0.000 claims abstract description 28
- 244000268590 Euryale ferox Species 0.000 claims abstract description 28
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 28
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 28
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 28
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 28
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 28
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 28
- 240000007817 Olea europaea Species 0.000 claims abstract description 28
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 28
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 28
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 27
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 27
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 27
- 229960004999 lycopene Drugs 0.000 claims abstract description 27
- 235000012661 lycopene Nutrition 0.000 claims abstract description 27
- 239000001751 lycopene Substances 0.000 claims abstract description 27
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 27
- 235000012907 honey Nutrition 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 24
- 240000002943 Elettaria cardamomum Species 0.000 claims abstract description 16
- 235000005300 cardamomo Nutrition 0.000 claims abstract description 16
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims abstract description 11
- 238000000605 extraction Methods 0.000 claims description 59
- 239000000463 material Substances 0.000 claims description 29
- 206010019133 Hangover Diseases 0.000 claims description 28
- 244000077995 Coix lacryma jobi Species 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 26
- 235000013399 edible fruits Nutrition 0.000 claims description 26
- 239000008187 granular material Substances 0.000 claims description 26
- 244000202052 Poncirus trifoliata Species 0.000 claims description 20
- 235000000404 Poncirus trifoliata Nutrition 0.000 claims description 20
- 244000248557 Ophiopogon japonicus Species 0.000 claims description 18
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 17
- 150000004676 glycans Chemical class 0.000 claims description 17
- 229920001282 polysaccharide Polymers 0.000 claims description 17
- 239000005017 polysaccharide Substances 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 244000059800 Amomum compactum Species 0.000 claims description 12
- 235000016426 Amomum compactum Nutrition 0.000 claims description 12
- 229930195210 Ophiopogon Natural products 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 20
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 abstract description 18
- 230000002633 protecting effect Effects 0.000 abstract description 18
- 210000000952 spleen Anatomy 0.000 abstract description 16
- 210000000582 semen Anatomy 0.000 abstract description 12
- 230000008673 vomiting Effects 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 8
- 230000001154 acute effect Effects 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 6
- 210000005036 nerve Anatomy 0.000 abstract description 6
- 239000001569 carbon dioxide Substances 0.000 abstract description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 3
- 230000002490 cerebral effect Effects 0.000 abstract description 3
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 210000004916 vomit Anatomy 0.000 abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 32
- 239000008213 purified water Substances 0.000 description 21
- 229940079593 drug Drugs 0.000 description 18
- 235000019359 magnesium stearate Nutrition 0.000 description 16
- 241000700159 Rattus Species 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000035622 drinking Effects 0.000 description 14
- 239000007884 disintegrant Substances 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 230000002526 effect on cardiovascular system Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 231100000331 toxic Toxicity 0.000 description 9
- 230000002588 toxic effect Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 7
- 108010082126 Alanine transaminase Proteins 0.000 description 7
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 7
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 7
- 238000001291 vacuum drying Methods 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010024264 Lethargy Diseases 0.000 description 4
- 206010067125 Liver injury Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 206010047141 Vasodilatation Diseases 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 208000028505 alcohol-related disease Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000007654 ischemic lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Insects & Arthropods (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Animal Husbandry (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210347978.XA CN114569686B (zh) | 2022-04-01 | 2022-04-01 | 一种解酒组合物、具有解酒功效的片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210347978.XA CN114569686B (zh) | 2022-04-01 | 2022-04-01 | 一种解酒组合物、具有解酒功效的片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114569686A true CN114569686A (zh) | 2022-06-03 |
CN114569686B CN114569686B (zh) | 2023-01-17 |
Family
ID=81778066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210347978.XA Active CN114569686B (zh) | 2022-04-01 | 2022-04-01 | 一种解酒组合物、具有解酒功效的片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114569686B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115624541A (zh) * | 2022-10-18 | 2023-01-20 | 吉林医药学院 | 一种外用解酒剂、解酒药贴及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150098525A (ko) * | 2014-02-20 | 2015-08-28 | 동아대학교 산학협력단 | 숙취해소 및 간 보호기능 개선용 건강기능성 조성물, 이를 포함하는 건강기능성 식품 및 식품첨가제 |
CN106267063A (zh) * | 2016-07-26 | 2017-01-04 | 张韩 | 一种护胃护肝解酒的中药组合物及其制备方法 |
CN106975069A (zh) * | 2017-05-02 | 2017-07-25 | 青岛康迈臣生物科技有限责任公司 | 一种保肝护肝组合物及其制备方法 |
CN110226687A (zh) * | 2019-06-12 | 2019-09-13 | 宁波依萃健生物科技有限公司 | 一种解酒护肝组合物及制备方法 |
CN111671026A (zh) * | 2020-07-31 | 2020-09-18 | 广东粤微食用菌技术有限公司 | 解酒醒酒保护胃肠道的姜黄复合解酒护肝饮及其制备方法 |
-
2022
- 2022-04-01 CN CN202210347978.XA patent/CN114569686B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150098525A (ko) * | 2014-02-20 | 2015-08-28 | 동아대학교 산학협력단 | 숙취해소 및 간 보호기능 개선용 건강기능성 조성물, 이를 포함하는 건강기능성 식품 및 식품첨가제 |
CN106267063A (zh) * | 2016-07-26 | 2017-01-04 | 张韩 | 一种护胃护肝解酒的中药组合物及其制备方法 |
CN106975069A (zh) * | 2017-05-02 | 2017-07-25 | 青岛康迈臣生物科技有限责任公司 | 一种保肝护肝组合物及其制备方法 |
CN110226687A (zh) * | 2019-06-12 | 2019-09-13 | 宁波依萃健生物科技有限公司 | 一种解酒护肝组合物及制备方法 |
CN111671026A (zh) * | 2020-07-31 | 2020-09-18 | 广东粤微食用菌技术有限公司 | 解酒醒酒保护胃肠道的姜黄复合解酒护肝饮及其制备方法 |
Non-Patent Citations (1)
Title |
---|
曾庆双等: "《中国白酒文化》", 31 August 2013 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115624541A (zh) * | 2022-10-18 | 2023-01-20 | 吉林医药学院 | 一种外用解酒剂、解酒药贴及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114569686B (zh) | 2023-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103549433B (zh) | 一种具有保肝护肝功效的中药保健食品 | |
US10111451B2 (en) | Food, beverage or pharmaceutical composition containing fermented eastern prickly pear and a preparation method therefor | |
CN101543248B (zh) | 一种特别适合“三高一酸”人群饮用的凉茶及其制备方法 | |
CN112546167A (zh) | 一种具有健脾利湿功能的中药组合物及其制备方法和应用 | |
CN108524673A (zh) | 一种中药组合物及其应用 | |
CN1294852C (zh) | 降火滋阴饮料 | |
CN101926882A (zh) | 治疗癌症的药物组合物及其制备方法 | |
CN114569686B (zh) | 一种解酒组合物、具有解酒功效的片剂及其制备方法 | |
CN104547636A (zh) | 一种适用于提高中老年人身体机能的中药组合物 | |
KR101045025B1 (ko) | 천식 치료 또는 예방용 약학조성물 | |
CN111135235A (zh) | 一种预防和缓解急性酒精中毒或醉酒的组合物 | |
CN100490883C (zh) | 天麻健脑药物 | |
CN107441429B (zh) | 一种解酒组合物及其制备方法 | |
KR20120093632A (ko) | 신장염 예방 또는 치료용 약학 조성물 | |
CN104274682A (zh) | 一种治疗煤工尘肺的中药组合物及其制备方法 | |
CN115089661A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物的应用 | |
CN108379500B (zh) | 一种养肝解酒醒酒防口臭的麦苗中药组合物及制备方法 | |
CN104800600A (zh) | 一种治疗高血压的药物 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN105641534A (zh) | 一种治疗咽喉肿痛的中药组合物、其药剂及其制备方法 | |
CN111821344A (zh) | 一种药酒及其制备方法 | |
CN108079271A (zh) | 一种治疗高血脂的药物组合物、制剂及其制备方法 | |
CN114668830B (zh) | 一种解酒护肝组合物及其制备方法 | |
CN114984179A (zh) | 一种治疗或预防米格列奈不良反应的组合物及其制备方法和应用 | |
CN104367870A (zh) | 一种预防和治疗高血糖、高血脂的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240124 Address after: Room 702, No. 1126 Shenbin South Road, Minhang District, Shanghai, 201107 Patentee after: Zaozuo Technology Co.,Ltd. Country or region after: China Address before: No. 3510, 35th Floor, Building 1, No. 500, Middle Section of Tianfu Avenue, Chengdu High tech Zone, China (Sichuan) Pilot Free Trade Zone, Chengdu City, Sichuan Province, 611833 Patentee before: Sichuan qianyiding Technology Co.,Ltd. Country or region before: China Effective date of registration: 20240124 Address after: No. 3510, 35th Floor, Building 1, No. 500, Middle Section of Tianfu Avenue, Chengdu High tech Zone, China (Sichuan) Pilot Free Trade Zone, Chengdu City, Sichuan Province, 611833 Patentee after: Sichuan qianyiding Technology Co.,Ltd. Country or region after: China Address before: 050000 Hebei University of science and technology, 26 Yuxiang street, Yuhua District, Shijiazhuang City, Hebei Province Patentee before: HEBEI University OF SCIENCE AND TECHNOLOGY Country or region before: China |